The DOI matches its Crossref record.
Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat.
Abstract
The effects of three dopamine D-1 receptor antagonists (SCH23390, SCH39166 and A69024) and three dopamine D-2 antagonists (raclopride, eticlopride and spiperone) on cocaine self-administration maintained under different schedules of reinforcement were examined in the rat. Intravenous cocaine self-administration was maintained under a fixed-ratio (FR) 5 schedule with a 20-sec timeout (TO) after each reinforcement or a FR 15 with a 2-min TO multiple schedule of cocaine (0.25 mg i.v.) and food (45 mg) reinforcement. With the exception of raclopride, all of the antagonists altered the self-administration of cocaine in a manner similar to decreasing the unit dose of cocaine under the schedule in effect, reflected by increased self-administration under the FR 5 TO 20-sec schedule and decreased self-administration under the FR 15 TO 2-min multiple schedule. Moreover, a low dose of either of the benzazepine dopamine D-1 antagonists SCH23390 or SCH39166, but not the other compounds, selectively reduced cocaine self-administration without altering responding for food under the multiple schedule. Conversely, a low dose of raclopride or A69024 selectively decreased food-reinforced responding without altering cocaine self-administration under the multiple schedule. These results suggest that benzazepine dopamine D-1 antagonists, at low doses, may attenuate the reinforcing properties of cocaine more selectively than other dopamine receptor antagonists. The results also demonstrate the advantages of using different schedules to investigate the effects of dopamine D-1 and D-2 antagonists on cocaine self-administration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“By contrast, DA receptor antagonists administered systemically increase the rate of operant responding for cocaine in animals [134-136].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [134]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Items 101–200 of 295
Self-administration of the D1 agonist SKF 82958 is mediated by D1, not D2, receptors
Self, D. W., Belluzzi, J. D., Kossuth, S. R., & Stein, L. (1996) · Psychopharmacology · doi:10.1007/bf02246638 · Cited by 61
Comparison of Olanzapine to Risperidone in Substance‐Abusing Individuals with Schizophrenia
Akerele, E., & LEVIN, F. R. (2007) · American Journal on Addictions · doi:10.1080/10550490701389658 · Cited by 63
Hyytiä, P., Bäckström, P., & Liljequist, S. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00446-x · Cited by 60
Doherty, J. M., Masten, V. L., Powell, S. B., Ralph, R. J., Klamer, D., Low, M. J., & Geyer, M. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301657 · Cited by 59
Haile, C. N., & Kosten, T. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29257-0 · Cited by 59
LeSage, M. G., Stafford, D. A., & Glowa, J. R. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00015-9 · Cited by 59
Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models
Jupp, B., & Dalley, J. W. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12787 · Cited by 58
Monoamine Transporter Inhibitors and Substrates as Treatments for Stimulant Abuse
Howell, L. L., & Negus, S. S. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00004-4 · Cited by 56
Activation of σ-Receptors Induces Binge-like Drinking in Sardinian Alcohol-Preferring Rats
Sabino, V., Cottone, P., Blasio, A., Iyer, M. R., Steardo, L., Rice, K. C., Conti, B., Koob, G. F., & Zorrilla, E. P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.5 · Cited by 56
Self-citationSinnott, R. S., Mach, R. H., & Nader, M. A. (1999) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00162-8 · Cited by 56
Heberlein, U., Tsai, L. T.-Y., Kapfhamer, D., & Lasek, A. W. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.023 · Cited by 57
Xi, Z., Zheng, Y., Li, S., Li, X., Dillon, C., Peng, X., Spiller, K. J., & Gardner, E. L. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.08.004 · Cited by 54
Muscarinic M4 receptor inhibition of dopamine D1-like receptor signalling in rat nucleus accumbens
Onali, P., & Olianas, M. C. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01910-6 · Cited by 54
Karasinska, J. M., George, S. R., El-Ghundi, M., Fletcher, P. J., & O’Dowd, B. F. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00347-2 · Cited by 52
Vezina, P., Pierre, P. J., & Lorrain, D. S. (1999) · Psychopharmacology · doi:10.1007/s002130051152 · Cited by 53
GABA Modulation of Cocaine Self‐Administration
Roberts, D. C. S., & Brebner, K. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06680.x · Cited by 54
Baird, T. J., Deng, S. X., Landry, D. W., Winger, G. D., & Woods, J. H. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39014-7 · Cited by 53
Maggos, C. E. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00009-8 · Cited by 52
Stevens, A., Schwarz, J. X. F. R., Schwarz, B., Ruf, I., Kolter, T., & Czekalla, J. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0974-1 · Cited by 52
Lamas, X., Negus, S. S., Mello, N. K., & Nader, M. A. (1996) · Psychopharmacology · doi:10.1007/bf02247435 · Cited by 52
The dopamine D3 receptor and drug addiction
Sokoloff, P., Foll, B. L., Perachon, S., Bordet, R., Ridray, S., & Schwartz, J.-C. (2001) · Neurotoxicity Research · doi:10.1007/bf03033202 · Cited by 51
Place conditioning with the dopamine D1-like receptor agonist SKF82958 but not SKF81297 or SKF77434
Abrahams, B. S., Rutherford, J. D., Mallet, P. E., & Beninger, R. J. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01531-8 · Cited by 51
Galaj, E., Ewing, S., & Ranaldi, R. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.03.020 · Cited by 51
Schenk, S. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0972-3 · Cited by 49
Galaj, E., Ananthan, S., Saliba, M., & Ranaldi, R. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3254-y · Cited by 48
Weissenborn, R. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01107-a · Cited by 47
Katz, J. L., Kopajtic, T. A., Myers, K. A., Mitkus, R. J., & Chider, M. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35097-9 · Cited by 47
Izzo, E., Orsini, C., Koob, G. F., & Pulvirenti, L. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00472-5 · Cited by 45
Self-citationOlanzapine attenuates the reinforcing effects of cocaine
Meil, W. M., & Schechter, M. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01351-4 · Cited by 46
HIV-1 proteins dysregulate motivational processes and dopamine circuitry
Bertrand, S. J., Mactutus, C. F., Harrod, S. B., Moran, L. M., & Booze, R. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-25109-0 · Cited by 40
Dopaminergic Mechanism for Caffeine-Produced Cocaine Seeking in Rats
Green, T. A. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00343-8 · Cited by 45
Effects of SCH 23390 and eticlopride on cocaine-seeking produced by cocaine and WIN 35,428 in rats
Schenk, S., & Gittings, D. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1276-y · Cited by 44
Khroyan, T. V., Platt, D. M., Rowlett, J. K., & Spealman, R. D. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1365-y · Cited by 44
Chausmer, A. L., & Ettenberg, A. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00388-7 · Cited by 44
Characterization of methylphenidate self-administration and reinstatement in the rat
Botly, L. C. P., Burton, C. L., Rizos, Z., & Fletcher, P. J. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1093-z · Cited by 43
Svensson, P., & Hurd, Y. L. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00041-2 · Cited by 43
Transgenic mice in drug dependence research
Pich, E. M., & Epping-Jordan, M. P. (1998) · Annals of Medicine · doi:10.3109/07853899809029939 · Cited by 42
Kohno, M., Dennis, L. E., McCready, H., & Hoffman, W. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01180-4 · Cited by 31
Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development
Foll, B. L., Wilson, A. A., Graff, A., Boileau, I., & Ciano, P. D. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00161 · Cited by 45
Norman, A. B., Norman, M. K., Buesing, W. R., Tabet, M. R., Tsibulsky, V. L., & Ball, W. J. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146407 · Cited by 41
Czoty, P. W., & Nader, M. A. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201012 · Cited by 41
Cornish, J. L., Lontos, J. M., Clemens, K. J., & McGregor, I. S. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2135-9 · Cited by 41
Biological substrates of addiction
Joffe, M. E., Grueter, C. A., & Grueter, B. A. (2014) · Wiley Interdisciplinary Reviews Cognitive Science · doi:10.1002/wcs.1273 · Cited by 42
Anti-Cocaine Vaccine Based on Coupling a Cocaine Analog to a Disrupted Adenovirus
Koob, G. F., Hicks, M. J., Wee, S., Rosenberg, J. B., De, B. P., Kaminksy, S. M., Moreno, A. Y., Janda, K. D., & Crystal, R. G. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711799219334 · Cited by 41
Self-citationDobbs, L. K., Kaplan, A. R., Bock, R., Phamluong, K., Shin, J. H., Bocarsly, M. E., Eberhart, L., Dorit Ron, A., & Alvarez, V. A. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0286-3 · Cited by 41
Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats
Miller, M. L., Aarde, S. M., Moreno, A. Y., Creehan, K. M., Janda, K. D., & Taffe, M. A. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.06.014 · Cited by 38
Dobbs, L. K., Lemos, J. C., & Alvarez, V. A. (2016) · Genes Brain & Behavior · doi:10.1111/gbb.12361 · Cited by 40
Targeting GABABreceptors for anti-abuse drug discovery
Phillips, T. J., & Reed, C. L. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.956076 · Cited by 37
Schenk, S. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00190-1 · Cited by 38
Dual effects of dextromethorphan on cocaine-induced conditioned place preference in mice
Jhoo, W., Shin, E., Lee, Y., Cheon, M.-A., Oh, K., Kang, S., Lee, C., Yi, B.-C., & Kim, H. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01188-5 · Cited by 38
Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats
Duarte, C., Biała, G., Bihan, C. L., Hamon, M., & Thiébot, M.-H. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1310-0 · Cited by 37
Lile, J. A. (2006) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.14.1.20 · Cited by 37
Rada, P. V., & Hoebel, B. G. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.12.016 · Cited by 36
Cocaine self-administration in dopamine D₃ receptor knockout mice.
Caine, S. B., Thomsen, M., Barrett, A. C., Collins, G. T., Grundt, P., Newman, A. H., Butler, P., & Xu, M. (2012) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0029135 · Cited by 34
Self-citationThiel, K. J., Wenzel, J. M., Pentkowski, N. S., Hobbs, R. J., Alleweireldt, A. T., & Neisewander, J. L. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.06.021 · Cited by 34
Accelerating Cocaine Metabolism as an Approach to the Treatment of Cocaine Abuse and Toxicity
Schindler, C. W., & Goldberg, S. R. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.11.181 · Cited by 34
Radell, M. L., Myers, C. E., Beck, K. D., Moustafa, A. A., & Allen, M. T. (2016) · Frontiers in Psychology · doi:10.3389/fpsyg.2016.01175 · Cited by 33
Caine, S. B., Negus, S. S., Mello, N. K., & Bergman, J. (2000) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.8.3.404 · Cited by 33
Self-citationEffects of nitric oxide on morphine self-administration in rat
Sahraei, H., Poorheidari, G., Foadoddini, M., Khoshbaten, A., Asgari, A., Noroozzadeh, A., Ghoshooni, H., Firoozabadi, S. H., & Zarrindast, M. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.10.008 · Cited by 33
Wang, W., Zhou, Y., Sun, J., Pan, L., Kang, L., Dai, Z., Yu, R., Jin, G.-Z., & Ma, L. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.08.006 · Cited by 32
McGinty, V. B., & Grace, A. A. (2009) · Journal of Neurophysiology · doi:10.1152/jn.91162.2008 · Cited by 39
D1 dopamine receptor activation of NFAT‐mediated striatal gene expression
Groth, R. D., Weick, J. P., Bradley, K. C., Luoma, J. I., Aravamudan, B., Klug, J. R., Thomas, M. J., & Mermelstein, P. G. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05980.x · Cited by 31
Testosterone and nucleus accumbens dopamine in the male Syrian hamster
Triemstra, J. L., Sato, S. M., & Wood, R. I. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.12.006 · Cited by 29
McGinty, V. B., & Grace, A. A. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.028 · Cited by 30
Stimulus control of cocaine self-administration.
Weiss, S. J., Kearns, D., Cohn, S. I., Schindler, C., & Panlilio, L. (2003) · Journal of The Experimental Analysis of Behavior · doi:10.1901/jeab.2003.79-111 · Cited by 28
Effects of drugs on food- and cocaine-maintained responding
Wojnicki, F. H. E., & Glowa, J. R. (1996) · Psychopharmacology · doi:10.1007/s002130050144 · Cited by 29
Smith, A. D., Smith, D. L., Zigmond, M. J., Amalric, M., & Koob, G. F. (2000) · Psychopharmacology · doi:10.1007/s002130050063 · Cited by 28
Self-citationDepletion of brain serotonin following intra-raphe injections
Fletcher, P. J., Korth, K. M., & Chambers, J. W. (1999) · Psychopharmacology · doi:10.1007/s002130051105 · Cited by 27
Presynaptic dopamine modulation by stimulant self-administration
España, R. A. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s371 · Cited by 27
Ferger, B., Stahl, D., & Kuschinsky, K. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169174 · Cited by 25
Veeneman, M. M. J., van Ast, M., Broekhoven, M. H., Limpens, J. H. W., & Vanderschuren, L. J. M. J. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2525-8 · Cited by 25
Hypocretin/Orexin Involvement in Reward and Reinforcement
España, R. A. (2012) · Vitamins and hormones · doi:10.1016/b978-0-12-394623-2.00010-x · Cited by 26
Dopamine release during cocaine self-administration in rats: effect of SCH23390
Egilmez, Y., Jung, M. E., Lane, J. D., & Emmett‐Oglesby, M. W. (1995) · Brain Research · doi:10.1016/0006-8993(95)00987-5 · Cited by 25
Ball, K. T., Combs, T. A., & Beyer, D. N. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.03.064 · Cited by 24
Carelli, R. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00064-9 · Cited by 24
Rocha, A., Valles, R., Cardon, A. L., Bratton, G. R., & Nation, J. R. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1742-1 · Cited by 24
Fletcher, P. J. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00559-5 · Cited by 23
Lateral septum inhibition reduces motivation for cocaine: Reversal by diazepam
Pantazis, C. B., & Aston‐Jones, G. (2019) · Addiction Biology · doi:10.1111/adb.12742 · Cited by 22
Dose–Effect Functions for Cocaine Self-Administration: Effects of Schedule and Dosing Procedure
Sizemore, G. M., Gaspard, T. M., Kim, S. A., Walker, L. E., Vrana, S. L., & Dworkin, S. I. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00437-6 · Cited by 23
Gu, S. M., Jin, H., Seo, S. W., Hong, J. T., & Yun, J. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01694-3 · Cited by 25
Maharajan, P., Maharajan, V., Ravagnan, G., & PAINO, G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00061-7 · Cited by 22
Dopamine D5Receptors in Nucleus Accumbens Contribute to the Detection of Cocaine in Rats
Filip, M., Thomas, M. L., & Cunningham, K. A. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-19-j0003.2000 · Cited by 22
Anti-cocaine vaccines: antibody protection against relapse
Kantak, K. M. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.2.213 · Cited by 21
Negus, S. S., & Banks, M. L. (2011) · doi:10.1002/9781118023150.ch11 · Cited by 21
Bidirectional role of dopamine in learning and memory-active forgetting
Díaz, F. C., Caffino, L., & Fumagalli, F. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.10.011 · Cited by 24
The Dopamine D1 Antagonist Reduces Ethanol Reward for C57BL/6 Mice
Price, K. L., & Middaugh, L. D. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000145783.39748.e6 · Cited by 20
Substance Abuse Among Patients with Schizophrenia
Akerele, E., & LEVIN, F. R. (2002) · Journal of Psychiatric Practice · doi:10.1097/00131746-200203000-00003 · Cited by 20
Claytor, R., Lile, J. A., & Nader, M. A. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.03.007 · Cited by 19
Bernardi, R. E., & Spanagel, R. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.08.024 · Cited by 19
Reinforcing effects of morphine are reduced in tissue plasminogen activator-knockout mice
Yi, Y., Yamada, K., Mizoguchi, H., Noda, Y., Nagai, T., Nitta, A., & Nabeshima, T. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.01.011 · Cited by 19
c‐Fos Is an Intracellular Regulator of Cocaine‐Induced Long‐Term Changes
Xu, M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1432.049 · Cited by 19
Relief of Pain-Depressed Behavior in Rats by Activation of D1-Like Dopamine Receptors
Lazenka, M. F., Freitas, K., Henck, S., & Negus, S. S. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.240796 · Cited by 18
Dunn, A. D., Windisch, K. A., Ben-Ezra, A., Pikus, P., Morochnik, M., Erazo, J., Reed, B., & Kreek, M. J. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05543-7 · Cited by 18
Brust, J. C. M. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7506-7313-6.50006-4 · Cited by 18
Mello, N. K. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00056-1 · Cited by 18
Stairs, D. J., Neugebauer, N. M., & Bardo, M. T. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833a5c9e · Cited by 17
Featherstone, R. E., Burton, C. L., Coppa-Hopman, R. D., Rizos, Z., Sinyard, J., Kapur, S., & Fletcher, P. J. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.05.010 · Cited by 16
Ramos, J., Hardin, E. J., Grant, A. H., Flores‐Robles, G., Gonzalez, A., Cruz, B., Martinez, A. K., Beltran, N. M., & Serafine, K. M. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.263293 · Cited by 15
The Inhibition of RasGRF2, But Not RasGRF1, Alters Cocaine Reward in Mice
Bernardi, R. E., Olevska, A., Morella, I., Fasano, S., Santos, E., Brambilla, R., & Spanagel, R. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1120-18.2019 · Cited by 14
Norman, A. B., Norman, M. K., Tabet, M. R., Tsibulsky, V. L., & Pesce, A. J. (2010) · Synapse · doi:10.1002/syn.20858 · Cited by 14
Metadata
- Authors
- Caine, S. B., & Koob, G. F.
- Affiliations
- Scripps Research Institute (US)
- ORCID
- Koob, G F
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 1994-07
- Volume
- 270
- Issue
- 1
- Pages
- 209-218
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W1943544645
- Cited by
- 298
- References
- 0
- Citations by year
- 2024: 3 · 2023: 2 · 2022: 4 · 2021: 5 · 2020: 8 · 2019: 7 · 2018: 5 · 2017: 5 · 2016: 9 · 2015: 4 · 2014: 13 · 2013: 5 · 2012: 7
- FWCI
- 3.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Funders
- National Institutes of Health (1f31da005478-01)
- National Institute on Drug Abuse (DA07348, DA 05478, DA04398, R01DA004398)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- cocaine self-administration, SCH 23390, raclopride, eticlopride, spiperone, reinforcement schedules, fixed-ratio schedules, multiple schedules, food reinforcement
- MeSH terms
- Animals, Behavior, Animal, Cocaine, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Interactions, Male, Reinforcement, Psychology, Self Administration, Rats, Wistar, Receptors, Dopamine D1, Rats, Dopamine D2 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review